JCCVS
Journal of Cardiology & Cardiovascular Surgery

Journal of Cardiology & Cardiovascular Surgery scientific, open-access, double-blind peer-reviewed journal covering a wide spectrum of topics in cardiology and cardiovascular surgery.

eISSN: 2980-1397
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Comparison of Pan-immune Inflammatory Index in patients dialysed via catheter and fistula
Abstract
Aims: Chronic kidney disease is a group of diseases associated with inflammatory processes, and the risk increases as the stage progresses. Increased inflammation in the disease is associated with mortality and morbidity, and diagnosis and treatment are very important. Arteriovenous fistula is recommended as the first choice for hemodialysis access. Some patients dialysed from catheters. We predict that catheters may cause a chronic inflammatory condition, and we planned this study to demonstrate this.
Methods: 242 patients from dialysis patients who applied to Kırıkkale University Internal Medicine Clinic, Ankara Private Balgat Dialysis Center and Yozgat Bozok University Internal Medicine Clinic were included in the study; demographic data (age, gender), history data (chronic diseases, continuously used medications), data regarding hemodialysis duration, laboratory data (HGB, WBC, PLT, MPV, neutrophil, monocyte, lymphocyte, C-reactive protein, urea, creatinine, glomerular filtration rate) of the patients were recorded. Pan-Immune Inflammatory Index (PII) ((neutrophil count x platelet count x monocyte count)/lymphocyte count) were calculated. Differences between hemodialysis vascular access and PII values were statistically analyzed in SPSS package program.
Results: According to hemodialysis vascular access routes, it was found that 182 (75.2%) of the patients had fistula dialysis, 60 (24.8%) had catheter dialysis and 85% of the individuals on catheter hemodialysis had permanent catheters, 15% had temporary catheters, 88% had jugular, and 12% had subclavian and femoral catheters. Inflammation levels were calculated with PII. While PII was calculated as 21125.33±39621.37 in patients undergoing hemodialysis through fistulas, it was calculated as 29745.24±50905.25 in patients undergoing hemodialysis through catheters (p=0.037*). In correlation analyses; A strong positive correlation was observed with lymphocyte, monocyte, neutrophil and platelet counts (respectively; 0.242**, 0.871**, 0.888**; 0.365**). A weak negative correlation was found with the duration of chronic kidney disease (-0.242*).
Conclusion: Since there is no directly related parameter developed for analyzing the level of inflammation, there is a need for formulation methods. PII is also a tool used for this purpose. In our study, we analyzed in which cases the increased oxidative stress in hemodialysis is higher with PII and the parameters that trigger it, and as a result, we found higher inflammation in patients hemodialyzed from catheters compared to patients hemodialyzed from fistulas. We concluded that the increased oxidative stress in chronic kidney disease can be further removed from the fistula by hemodialysis or that oxidative stress caused by foreign bodies such as catheters may be higher. For a more definitive decision, further examination is needed by evaluating before and after hemodialysis and examining individuals with chronic kidney disease who are on hemodialysis and those who are not.

Keywords : Chronic kidney disease, inflammation, Pan-Immune Inflammatory Index, , catheter, fistula

Download Article


1. Dai L, Golembiewska E, Lindholm B, Stenvinkel P. End-stage renal disease, inflammation and cardiovascular outcomes. Contrib Nephrol. 2017;191:32-33. doi:10.1159/000479254
2. Gupta J, Mitra N, Kanetsky PA, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012;7(12):1938-46. doi:10.2215/CJN.02020212
3. Jankowska M, Cobo G, Lindholm B, Stenvinkel P. Inflammation and protein-energy wasting in the uremic milieu. Contrib Nephrol. 2017;191: 58-71. doi:10.1159/000479256
4. Cobo G, Lindholm B, Stenvinkel P. Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant. 2018;33(3):35-40. doi:10.1093/ndt/gfy175
5. Akar HH, Köse M. Enflamatuar biyobelirteçler. TÜSAD Kitapları: Çocuk Göğüs Hastalıkları Kitabı. 2016.
6. Balçık OY, Bora F, Köksoy S, Ersoy FF. Evre 3-5 kronik böbrek hastalarında hematopoetik hücrelerdeki vitamin D reseptör düzeyi ile inflamasyon belirteçlerinin değerlendirilmesi. Akd Med J. 2021;8(3): 333-341. doi:10.53394/akd.1059539
7. Türkoğlu S, Yılmaz FC. Kronik böbrek hastalarında beslenme durumunun ve malnütrisyon inflamasyon skorunun belirlenmesi: kesitsel bir araştırma. Turkiye Klinikleri Journal of Health Sciences. 2022;7(3):678-684. doi:10.5336/healthsci.2022-88994
8. Korkmaz SA, Topbaş E. Böbrek sağlığının korunması ve böbrek hastalıklarının önlenmesinde ulusal ve uluslararası eylem planları. NefroHemDergi. 2023;18(1):45-61. doi:10.47565/ndthdt.2023.67
9. Seyahi N, Süleymanlar G. Türkiye’de renal replasman tedavilerinin güncel durumu: Türk Nefroloji Derneği kayıt sistemi 2014 yılı özet raporu. Turk Neph Dial Transpl. 2018;27(2):133-139. doi:10.5262/tndt. 2016.1002.02
10. Bailie GR, Larkina M. Clinical outcomes and complications in hemodialysis patients with central venous catheters versus arteriovenous fistulas. Kidney Int. 2020;97(6):1193-1204. doi:10.1016/j.kint.2019.12.008
11. Foley RN, Collins AJ. End-stage renal disease in the United States: an update on the epidemiology and health outcomes. Kidney Int. 2011;79(4):290-296. doi:10.1038/ki.2010.446
12. Murray MD, Smith MR. Inflammatory markers in chronic kidney disease and dialysis. Kidney Dis. 2019;5(3):145-153. doi:10.1159/ 000504244
13. Pohl MA, Hsu RK. Immune system activation in dialysis patients: impact of arteriovenous access type. Nephrol Dial Transplant. 2022; 37(11):1982-1990. doi:10.1093/ndt/gfz139
14. Snaedal SJ, Gislason GH. Impact of central venous catheters on dialysis-related infection risk and outcomes. Hemodial Int. 2015;19(3):305-313. doi:10.1111/hdi.12285
15. Hernandez LA, Salazar JF. Comparative analysis of inflammatory responses in dialysis patients with different vascular access types. Clin Nephrol. 2017;88(2):86-92.
16. National Nephrology, Dialysis and Transplantation Registry Report of Turkey 2023.
17. Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4):1-164. doi:10. 1053/j.ajkd.2019.12.001
18. Çiftçi D, Tüzün Özdemir S, Karadakovan A. Böbrek hastalıklarını önlemeye yönelik evrensel önlemler. Sunum. 2. Uluslararası Sağlık Araştırmaları Kongresi (ICOHER’22); 2022; İstanbul, Türkiye.
19. Panizo S, Martínez-Arias L, Alonso-Montes C, et al. Fibrosis in chronic kidney disease: pathogenesis and consequences. Int J Mol Sci. 2021; 22(1):408. doi:10.3390/ijms22010408
20. Ponce D, Nitsch D, Ikizler TA. Strategies to prevent infections in dialysis patients. Semin Nephrol. 2023;43(5):151467. doi:10.1016/j.semnephrol.2023.151467
21. Jesudason S, Hewawasam E, Moloney B, et al. Comparison of catheters or new arteriovenous fistulas for commencement of haemodialysis in pregnant women with chronic kidney disease: an international observational study. J Nephrol. 2022;35(6):1689-1698. doi:10.1007/s 40620-022-01288-y
22. Can İN. Hastane kökenli pnömoni etkeni Klebsiella ve Acinetobacter kökenlerinde biyofilm yapımı ve antibakteriyel duyarlılığın araştırılması [tez]. İzmir: Dokuz Eylül Üniversitesi; 2021.
23. Çantay H, Anuk T, Sülü B, Binnetoğlu K, Allahverdi T, Gönüllü D. Üst gastrointestinal sistemde yabancı cisimlerin değerlendirilmesi: tanı ve tedavi. The Med J Mustafa Kemal Univ. 2021;12(44):186-190. doi:10. 17944/mkutfd.935615
24. Malyszko J, Malyszko JS, Koc-Zorawska E, Kozminski P, Mysliwiec M. Neutrophil gelatinase-associated lipocalin in dialyzed patients is related to residual renal function, type of renal replacement therapy and inflammation. Kidney Blood Press Res. 2010;32(6):464-469. doi:10.1159/ 000321021
25. Doğan İ, Kahvecioğlu S, Eser B, et al. Periton diyaliz hastalarında serum apelin-13’ün inflamasyon ve kardiyak morfoloji için önemi. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi. 2018;27(2):133-139.
26. Mohammed ZN. Diyaliz hastalarında galektin-3 ve asimetrik dimetilarginin (ADMA) ilişkisi. Selçuk Üniversitesi, Sağlık Bilimleri Enstitüsü. 2024.
27. Aygün D, Dundar B. The relationship between leukocyte-based inflammation indices and essential tremor. Turk J Clin Lab. 2024;15(3): 473-480. doi:10.18663/tjcl.1503503
28. Ermurat S, Tezcan D. Sistemik lupus eritematozus hastalarında inflamasyon belirteci ve yüksek hastalık aktivite göstergesi olarak yeni hematolojik indeksler. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2022; 48(2):189-196. doi:10.32708/uutfd.1110778
29. Gao C, Gao S, Zhao R, et al. Association between systemic immune-inflammation index and cardiovascular-kidney-metabolic syndrome. Sci Rep. 2024;14(1):19151. doi:10.1038/s41598-024-69819-0
30. Gu L, Xia Z, Qing B, et al. Systemic inflammatory response index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001-2018). Front Immunol. 2024;15:1338025. doi:10.3389/fimmu.2024. 1338025
31. Tuzimek A, Dziedzic EA, Beck J, Kochman W. Correlations between acute coronary syndrome and novel inflammatory markers (systemic immune-inflammation index, systemic inflammation response index, and aggregate index of systemic inflammation) in patients with and without diabetes or prediabetes. J Inflamm Res. 2024;17:2623-2632. doi: 10.2147/JIR.S454117
32. Huang D, He Q, Pan J, et al. Systemic immune-inflammatory index predicts fragility fracture risk in postmenopausal anemic females with type 2 diabetes mellitus: evidence from a longitudinal cohort study. BMC Endocr Disord. 2024;24(1):256. doi:10.1186/s12902-024-01792-1
33. Xiu J, Lin X, Chen Q, et al. The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension. Front Cardiovasc Med. 2023; 10:1163900. doi:10.3389/fcvm.2023.1163900 </ol> <p>
Article available in :
Volume 3, Issue 2, 2025
Page : 29-34
https://doi.org/10.51271/JCCVS-0054
Article Information
Received : 28 May 2025
Accepted : 25 Haz 2025
Published : 27 Haz 2025
Corresponding Author :

Duygu Felek: Department of Internal Medicine, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkiye

[email protected]
Citation : Öztürk H, Felek D, Varlıbaş A, Hacıömeroğlu A, Öztürk ZN, Çifci A. Comparison of Pan-Immune Inflammatory Index in patients dialysed from catheters and fistulas. J Cardiol Cardiovasc Surg. 2025;3(2):29-34.

Read: 298
Download : 141
Cited: 0
_Footer